Ocular immune privilege
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
The eye attempts to limit local immune and inflammatory responses to preserve vision. This phenomenon, known as ocular immune privilege, is mediated by a combination of local and systemic mechanisms. While immune privilege is believed to protect the eye from day-to-day inflammatory insults, it is not absolute and its mechanisms are still incompletely understood.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The small size, accessibility, confined structure, and immune-privileged status of the eye [74, 75], make it an ideal target for gene therapy”
From The economic impact of retinal diseases for which gene therapy is emerging: a systematic literature review (2025) · cites this paper as [75]
Experimental — accuracy not yet measuredIn the citing paper
“it has been shown that the eye exhibits physical barriers (e.g., blood-retina-barrier preventing free entry of systemic immune cells) as well as cell-bound and soluble immunosuppressive factors11,12.”
From Investigation of Cas9 Antibodies in the Human Eye (2022) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Medawar, P. B. (1948) · PubMed · Cited by 1,109
Ocular immune privilege: therapeutic opportunities from an experiment of nature
Streilein, J. W. (2003) · Nature Reviews Immunology · doi:10.1038/nri1224 · Cited by 807 · cited 1×
“that have recovered fromexperimental autoimmuneuveitis (EAU) contain regulatory activity, whose generation is dependent on the presence of eye [7-9].”
BackgroundOcular immune privilege: the eye takes a dim but practical view of immunity and inflammation
Streilein, J. W. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.1102574 · Cited by 367
Spontaneous autoimmunity prevented by thymic expression of a single self-antigen
DeVoss, J., Hou, Y., Johannes, K., Lu, W., Liou, G. I., Rinn, J., Chang, H., Caspi, R. R., Fong, L., & Anderson, M. S. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061864 · Cited by 275
Self-citationSTEIN-STREILEIN, J., & STREILEIN, J. W. (2002) · International Reviews of Immunology · doi:10.1080/08830180212066 · Cited by 218 · cited 1×
“It involvesmigration from the eye to the spleen of F4/80 antigen-presenting cells that interact with invariant natural killer T cells and B cells and culminates in elicitation of systemic regulatory immunity through induction of CD4 afferent and CD8 efferent Treg cells (reviewed in [4,6]).”
BackgroundOcular autoimmunity: the price of privilege?
Caspi, R. R. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00439.x · Cited by 162
Self-citationOcular Immunosuppressive Microenvironment
Taylor, A. W. (2007) · KARGER eBooks · doi:10.1159/000099255 · Cited by 160
Retinal Pigment Epithelium-Derived CTLA-2α Induces TGFβ-Producing T Regulatory Cells,
Sugita, S., Horie, S., Nakamura, O., Futagami, Y., Takase, H., Keino, H., Aburatani, H., Katunuma, N., Ishidoh, K., Yamamoto, Y., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.11.7525 · Cited by 126
Organ-Resident, Nonlymphoid Cells Suppress Proliferation of Autoimmune T-Helper Lymphocytes
Caspi, R. R., ROBERGE, F. G., & Nussenblatt, R. B. (1987) · Science · doi:10.1126/science.2956685 · Cited by 123
Self-citationSugita, S., Usui, Y., Horie, S., Futagami, Y., Aburatani, H., Okazaki, T., Honjo, T., Takeuchi, M., & Mochizuki, M. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2846 · Cited by 99
Cited by
VEGFR1 signaling in retinal angiogenesis and microinflammation
Uemura, A., Fruttiger, M., D'Amore, P. A., De Falco, S., Joussen, A. M., Sennlaub, F., Brunck, L. R., Johnson, K. T., Lambrou, G. N., Rittenhouse, K. D., et al. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100954 · Cited by 354
CHECKPOINT INHIBITOR IMMUNE THERAPY: Systemic Indications and Ophthalmic Side Effects
Dalvin, L. A., Shields, C. L., Orloff, M., Sato, T., & Shields, J. A. (2018) · Retina · doi:10.1097/iae.0000000000002181 · Cited by 336
Human Corneal Endothelial Cell Expansion for Corneal Endothelium Transplantation: An Overview
Peh, G. S. L., Beuerman, R. W., Colman, A., Tan, D. T., & Mehta, J. S. (2011) · Transplantation · doi:10.1097/tp.0b013e3182111f01 · Cited by 242
Immune mechanisms in inflammatory and degenerative eye disease
Perez, V. L., & Caspi, R. R. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.04.003 · Cited by 188
Self-citationGasparini, S. J., Llonch, S., Borsch, O., & Ader, M. (2019) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.11.001 · Cited by 186
Metadata
- Authors
- Zhou, R., & Caspi, R. R.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Caspi, Rachel R
- Venue
- F1000 Biology Reports
- Publisher
- H1 Connect
- Published
- 2010-01-18
- Volume
- 2
- ISSN
- 1757-594X (ISSN-L)
- DOI
- 10.3410/b2-3
- PMC
- PMC2948372
- OpenAlex
- W2132060134
- Cited by
- 259
- References
- 18
- Citations by year
- 2026: 10 · 2025: 25 · 2024: 32 · 2023: 23 · 2022: 31 · 2021: 23 · 2020: 31 · 2019: 14 · 2018: 22 · 2017: 14 · 2016: 11 · 2015: 9 · 2014: 2 · 2013: 2 · 2012: 7
- FWCI
- 4.19
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- F1000 Biology Reports (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
- Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
- Keywords
- ocular immune privilege, eye, inflammation, vision preservation, local immune regulation, ocular immunity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ocular immune privilege. https://app.cochat.ai/papers/10.3410/b2-3
- The paper
- Zhou, R., & Caspi, R. R. (2010). Ocular immune privilege. F1000 Biology Reports. https://doi.org/10.3410/b2-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.